Latest Global Expansion News

Bioxyne Ltd has secured a manufacturing agreement with global cannabis giant Aurora Cannabis, marking a major step in its international expansion of pharmaceutical-grade medicinal cannabis products.

BrainChip Holdings has inked a global licensing agreement with Korea’s EDGEAI, granting access to its Akida 2 neuromorphic AI technology for EDGEAI’s upcoming semiconductor products. The deal includes milestone payments and royalties, marking a significant step in BrainChip’s global expansion and the growing edge AI market.

HyTerra Limited has partnered with Omani operator ARA Natural Resources to explore geologic hydrogen opportunities in Oman’s Semail Ophiolite, aiming to pioneer commercialisation in a promising low-carbon energy frontier.

PainChek has reported a strong quarter in the UK aged care sector, securing 4,000 new licenses and driving 9% quarter-on-quarter growth, signalling rising demand for its AI-driven pain assessment technology.

Nexsen Limited is advancing its rapid Group B Streptococcus test, StrepSure®, with a clear FDA submission timeline and early market entries across Asia-Pacific and emerging regions.

Orbital UAV has secured a pivotal engine order for heavy-lift drones, expanded its diagnostic support with Textron Systems, and entered a strategic MoU to participate in a NATO-aligned UAV program.

Klevo Rewards’ subsidiary Fly Wallet has gained multi-jurisdictional certification, paving the way for its corporate card programs across 18 international markets.

Ovanti Limited launches its One Financial Superapp powered by Isentric, combining instant payments, DeFi yields, BNPL, and AI financial advisory in a unified platform targeting underbanked markets.

Evion Group is advancing the Stage 2 expansion of its expandable graphite facility in India to boost production capacity amid rising demand from Europe, the USA, and Asia. The upgrade aligns with the EU’s recognition of graphite as a critical mineral, positioning Evion as a key supplier in strategic sectors.

Ovanti Limited is reshaping its future with a strategic shift from its BNPL roots to a global financial Super App, exiting legacy US operations to focus on innovation and international expansion.

Shriro Holdings Limited has announced a $15 million off-market share buy-back at $0.81 per share, representing nearly 26% of its issued capital. The move aims to return excess capital to shareholders while supporting the company’s capital-light growth model.

Orthocell has appointed LEDA Orthopaedics as the exclusive distributor for its Remplir™ nerve repair product in the UK, positioning itself for a rapid commercial launch pending regulatory approval.